Adams TS, Schupp JC, Poli S et al (2020) Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv 6:eaba1983. https://doi.org/10.1126/sciadv.aba1983

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aubry M-C, Myers JL, Douglas WW et al (2002) Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 77:763–770. https://doi.org/10.4065/77.8.763

Article  PubMed  Google Scholar 

Barrett T, Wilhite SE, Ledoux P et al (2013) NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res 41:D991-995. https://doi.org/10.1093/nar/gks1193

Article  CAS  PubMed  Google Scholar 

Brown S-AW, Dobelle M, Padilla M et al (2019) Idiopathic pulmonary fibrosis and lung cancer. A systematic review and meta-analysis. Annals ATS 16:1041–1051. https://doi.org/10.1513/AnnalsATS.201807-481OC

Article  Google Scholar 

Chen LX, Ni XL, Zhang H et al (2018) Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer. Int J Nanomedicine 13:2463–2476. https://doi.org/10.2147/IJN.S159327

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T-Y, Li X, Hung C-H et al (2020) The relaxin family peptide receptor 1 (RXFP1): an emerging player in human health and disease. Mol Genet Genomic Med 8:e1194. https://doi.org/10.1002/mgg3.1194

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Zhu X, Shen X et al (2023) IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. Immunopharmacol Immunotoxicol 45:370–377. https://doi.org/10.1080/08923973.2022.2150636

Article  CAS  PubMed  Google Scholar 

Cheng D, Abudikeranmu Y, Tuerdi B (2023) Differentiation of clear cell and non-clear-cell renal cell carcinoma through CT-based radiomics models and nomogram. Curr Med Imaging 19:1005–1017. https://doi.org/10.2174/1573405619666221121164235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conte E, Gili E, Fruciano M et al (2013) PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Lab Invest 93:566–576. https://doi.org/10.1038/labinvest.2013.6

Article  CAS  PubMed  Google Scholar 

DePianto DJ, Chandriani S, Abbas AR et al (2015) Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70:48–56. https://doi.org/10.1136/thoraxjnl-2013-204596

Article  PubMed  Google Scholar 

Elliot S, Periera-Simon S, Xia X et al (2019) MicroRNA let-7 downregulates ligand-independent estrogen receptor–mediated male-predominant pulmonary fibrosis. Am J Respir Crit Care Med 200:1246–1257. https://doi.org/10.1164/rccm.201903-0508OC

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esposito D, Dudley-Fraser J, Garza-Garcia A, Rittinger K (2022) Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity. Nat Commun 13:7583. https://doi.org/10.1038/s41467-022-35300-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng S, Agoulnik IU, Bogatcheva NV et al (2007) Relaxin promotes prostate cancer progression. Clin Cancer Res 13:1695–1702. https://doi.org/10.1158/1078-0432.CCR-06-2492

Article  CAS  PubMed  Google Scholar 

Fenocchio E, Depetris I, Campanella D et al (2016) Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report. BMC Cancer 16:793. https://doi.org/10.1186/s12885-016-2833-9

Article  PubMed  PubMed Central  Google Scholar 

Fu F, Tao X, Jiang Z et al (2023) Identification of germline mutations in East-Asian young never-smokers with lung adenocarcinoma by whole-exome sequencing. Phenomics 3:182–189. https://doi.org/10.1007/s43657-022-00062-1

Article  CAS  PubMed  Google Scholar 

Hendriks LEL, Drent M, van Haren EHJ et al (2012) Lung cancer in idiopathic pulmonary fibrosis patients diagnosed during or after lung transplantation. Respir Med Case Rep 5:37–39. https://doi.org/10.1016/j.rmedc.2011.10.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holaska JM, Rais-Bahrami S, Wilson KL (2006) Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes. Hum Mol Genet 15:3459–3472. https://doi.org/10.1093/hmg/ddl423

Article  CAS  PubMed  Google Scholar 

Hu Q, Guo C, Li Y et al (2011) LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration. Mol Cell Biol 31:3223–3240. https://doi.org/10.1128/MCB.01365-10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Gai Y, Yang N et al (2011) Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am J Pathol 179:2751–2765. https://doi.org/10.1016/j.ajpath.2011.08.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hubbard R, Venn A, Lewis S, Britton J (2000) Lung cancer and cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 161:5–8. https://doi.org/10.1164/ajrccm.161.1.9906062

Article  CAS  PubMed  Google Scholar 

Hutchinson J, Fogarty A, Hubbard R, McKeever T (2015) Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 46:795–806. https://doi.org/10.1183/09031936.00185114

Article  PubMed  Google Scholar 

JafariNezhad A, YektaKooshali MH (2018) Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS ONE 13:e0202360. https://doi.org/10.1371/journal.pone.0202360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang N, Zou C, Zhu Y et al (2020) HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling. Theranostics 10:2553–2570. https://doi.org/10.7150/thno.41120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin X, Di X, Wang R et al (2019) RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway. J Cell Mol Med 23:3897–3904. https://doi.org/10.1111/jcmm.14263

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kan J, Fu B, Zhou R et al (2022) He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway. Phytomedicine 94:153821. https://doi.org/10.1016/j.phymed.2021.153821

Article  CAS  PubMed  Google Scholar 

Karnoub AE, Weinberg RA (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9:517–531. https://doi.org/10.1038/nrm2438

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kato E, Takayanagi N, Takaku Y et al (2018) Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis. ERJ Open Res 4:00111–02016. https://doi.org/10.1183/23120541.00111-2016

Article  PubMed  PubMed Central  Google Scholar 

Katono K, Sato Y, Kobayashi M et al (2017) Clinicopathological significance of S100A14 expression in lung adenocarcinoma. Oncol Res Treat 40:594–602. https://doi.org/10.1159/000478100

Article  CAS  PubMed  Google Scholar 

King TE, Pardo A, Selman M (2011) Idiopathic pulmonary fibrosis. The Lancet 378:1949–1961. https://doi.org/10.1016/S0140-6736(11)60052-4

Article  Google Scholar 

Kowalski JP, McDonald MG, Whittington D et al (2019) Structure-activity relationships for CYP4B1 bioactivation of 4-ipomeanol congeners: direct correlation between cytotoxicity and trapped reactive intermediates. Chem Res Toxicol 32:2488–2498. https://doi.org/10.1021/acs.chemrestox.9b00330

Article  CAS  PubMed  Google Scholar 

Le Jeune I, Gribbin J, West J et al (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 101:2534–2540. https://doi.org/10.1016/j.rmed.2007.07.012

Article  PubMed  Google Scholar 

Lederer DJ, Martinez FJ (2018) Idiopathic pulmonary fibrosis. N Engl J Med 378:1811–1823. https://doi.org/10.1056/NEJMra1705751

Article  CAS  PubMed  Google Scholar 

Li X, Ma X, Miao Y et al (2023) Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway. J Cell Mol Med 27:422–434. https://doi.org/10.1111/jcmm.17665

Article  CAS  PubMed  PubMed Central